Advanced Stage Hodgkin Lymphoma: Patient Management.
Journal
Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064
Informations de publication
Date de publication:
25 05 2020
25 05 2020
Historique:
received:
25
05
2020
accepted:
25
05
2020
entrez:
12
6
2020
pubmed:
12
6
2020
medline:
26
3
2021
Statut:
epublish
Résumé
Hodgkin lymphoma (HL) is a rare cancer of the lymphoid system. It clinically presents with swollen lymph nodes and/or systemic symptoms, such as fever, night sweats, or weight loss, as signs of a more advanced stage disease. For the purpose of treatment allocation, HL cases are classified as early-stage favorable, early-stage unfavorable, and advanced-stage disease. Here below we describe four different clinical cases from real life that address some key issues and medical needs that are present in the daily practice with patients affected by advanced stage HL. The four clinical cases are quite heterogeneous, but in each case there are strong inputs to manage a specific category of advanced phase HL patient that is going to be treated with first-line therapy.
Identifiants
pubmed: 32525129
doi: 10.23750/abm.v91iS-5.9913
pmc: PMC7944653
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5-12Références
J Clin Oncol. 2018 Feb 10;36(5):454-462
pubmed: 29360414
J Clin Oncol. 2007 Aug 20;25(24):3746-52
pubmed: 17646666
N Engl J Med. 2010 Nov 4;363(19):1812-21
pubmed: 21047225
Ann Oncol. 2005 Jan;16(1):116-23
pubmed: 15598948
Lancet. 2002 Jun 15;359(9323):2065-71
pubmed: 12086759
F1000Res. 2018 Nov 13;7:
pubmed: 30473768
J Clin Oncol. 2016 Jun 10;34(17):2020-7
pubmed: 27069074
Lancet. 2012 Sep 1;380(9844):836-47
pubmed: 22835602
Lancet. 1993 Apr 24;341(8852):1051-4
pubmed: 8096958
J Clin Oncol. 2016 Apr 20;34(12):1376-85
pubmed: 26884559
Lancet Oncol. 2013 Dec;14(13):1348-56
pubmed: 24239220
Blood. 2006 Jan 1;107(1):52-9
pubmed: 16150944
Ann Oncol. 2005 Jul;16(7):1160-8
pubmed: 15939713
Haematologica. 2007 Jan;92(1):35-41
pubmed: 17229633
Am J Hematol. 2010 May;85(5):320-4
pubmed: 20229590
J Clin Oncol. 2014 Sep 20;32(27):3048-58
pubmed: 25113771
J Clin Oncol. 2010 Dec 1;28(34):5074-80
pubmed: 20975066
J Clin Oncol. 2012 Jun 20;30(18):2183-9
pubmed: 22454421
N Engl J Med. 2016 Jun 23;374(25):2419-29
pubmed: 27332902